Home > Nanotechnology Columns > Bergeson & Campbell, P.C. >
 |
Lynn L. Bergeson Managing Director Bergeson & Campbell, P.C. |
Abstract:
The Organization for Economic Cooperation and Development has published a draft Study Report on Applicability of the key event based TG 442D for in vitro skin sensitisation testing of nano-materials.
December 23rd, 2022
The Organization for Economic Cooperation and Development has published a draft Study Report on Applicability of the key event based TG 442D for in vitro skin sensitisation testing of nano-materials. See https://www.oecd.org/chemicalsafety/testing/draft-study-report-test-guideline-442D-in-vitro-skin-sensitisation-nanomaterials.pdf The study summary and conclusions include the following questions and answers (Q&A):
- Is the Test Guideline (TG) technically applicable?
Yes, OECD TG 442D (KeratinoSensTM test method) is from a technical point of view applicable for the testing of manufactured nanomaterials. The draft report notes that it was not possible to make any assumption about the relevance for the in vivo correlation due to the scarce availability of data for manufactured nanomaterials that have been tested in vivo. Nevertheless, the work conducted within this project can be seen as a starting point for further work with regard to manufactured nanomaterials safety testing for skin sensitization.
- Which nanomaterials are suitable for testing?
Different manufactured nanomaterials were selected for testing based on an extensive literature review and dependent on information about their skin sensitizing potential. In total, 12 inorganic and organic manufactured nanomaterials were selected (nine test materials, three controls). Testing with KeratinoSensTM was from a technical point of view possible with all of the selected manufactured nanomaterials.
- Are there nanomaterials that were not possible to test?
During the practical part of this study, there were no manufactured nanomaterials identified that could not be tested. The draft study notes that the sample number of 12 manufactured nanomaterials is relatively small in comparison to the variety of manufactured nanomaterials, however, and the authors cannot conclude whether there is one manufactured nanomaterials group that cannot be tested using KeratinoSensTM. According to the draft study, the critical step might be the sample preparation. If a manufactured nanomaterial cannot be dispersed to be tested in the respective media for KeratinoSensTM, it cannot be tested in this assay.
- What has to be adapted to use the TG for nanomaterials?
According to the experience gained during the testing of selected manufactured nanomaterials with the KeratinoSensTM and based on the discussion within the two expert workshops in December 2019 and 2021, some recommendations can be made with regard to the dispersion protocols, needs for endotoxin assays, potential to include leaching experiments, and the role of dimethyl sulfoxide (DMSO) as a mediator to assist nanomaterial penetration into cells. Further, the potential for nanomaterials to interact with detection methodologies also brought in the possibility to use two different colorimetric cytotoxicity assays.
- Are protocol changes needed to test nanomaterials?
Some of the recommendations made under the previous point can be directly addressed by adaptation of the standard operating procedures (SOP) of the KeratinoSensTM test method, e.g., viability assessment.
Comments are due January 31, 2023.
Bookmark:
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||